NTR — Nutrien Income Statement
0.000.00%
- $27.12bn
- $40.71bn
- $25.97bn
- 94
- 85
- 84
- 99
Annual income statement for Nutrien, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 20,908 | 27,712 | 37,884 | 29,056 | 25,972 |
| Cost of Revenue | |||||
| Gross Profit | 5,153 | 9,068 | 14,515 | 8,195 | 7,369 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 20,025 | 23,073 | 27,075 | 26,311 | 24,116 |
| Operating Profit | 883 | 4,639 | 10,809 | 2,745 | 1,856 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 382 | 4,168 | 10,246 | 1,952 | 1,136 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 459 | 3,179 | 7,687 | 1,282 | 700 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 459 | 3,153 | 7,660 | 1,258 | 674 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 459 | 3,153 | 7,660 | 1,258 | 674 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.61 | 5.87 | 13.2 | 3.94 | 2.43 |
| Dividends per Share |